To make a neuromuscular division appointment, call 617-726-3642.
- Clinical Interests
- Amyotrophic lateral sclerosis (ALS)
- Medical Education
- MD, MPH, Northwestern University, Feinberg School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital|Fellowship, Massachusetts General Hospital
- Board Certifications
- Neuromuscular Medicine
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Dr. Berry provides care for people with amyotrophic lateral sclerosis (ALS). He is the director of the Massachusetts General Hospital (MGH) multidisciplinary amyotrophic lateral sclerosis (ALS) clinic and Chief of the Division of ALS and Motor Neuron Diseases. He has worked to better serve people with ALS by building the tools and team required to extend the reach of the MGH clinic team beyond the walls of the physical clinic. The ALS House Call program and video televisit program are examples of exciting initiatives at the MGH ALS clinic.
Dr. Berry also works as an ALS researcher, designing, overseeing, and carrying out trials at MGH and centers across the country. His work is focused on the identification of markers of ALS in blood and spinal fluid, with an emphasis on markers of abnormal inflammation. He collaborates broadly with researchers around the globe on these biomarker efforts. He is also actively working to develop mobile health and digital phenotyping methods to better understand ALS and hasten the development of new therapies, while reducing the burden of trial participation for people with ALS.
Dr. Berry is also the Associate Director of the MGH Neurological Clinical Research Institute (NCRI) and Director of the Partners Neurodegenerative Clinical Research Fellowship. He is a member of the Massachusetts ALS Registry team and CDC/ATSDR National ALS Registry and Biorepository Expert Panels. In addition, he is on the Executive Committee of the NEALS Consortium, a national organization for ALS clinical researchers, where he also leads the NEALS Biorepository and Technology in ALS subcommittee.
Funds raised from the event will support ALS research programs, including the Healey Center for ALS Platform Trial.
15 Parkman Street
Boston, MA 02114-3117
165 Cambridge Street
Boston, MA 02114-2783